Compare Stocks

Date Range: 

 Align TechnologyColoplast A/SEdwards LifesciencesZimmer BiometSmith & Nephew
SymbolNASDAQ:ALGNOTCMKTS:CLPBYNYSE:EWNYSE:ZBHNYSE:SNN
Price Information
Current Price$695.80$18.45$112.27$163.42$40.93
50-Day Moving Average$612.59$16.58$102.86$161.03$43.02
52-Week Low$279.83$13.64$70.92$129.15$34.29
52-Week High$697.87$18.51$114.22$180.36$46.10
MarketRank™
Overall Score2.31.62.22.92.1
Analysis Score2.50.02.33.52.4
Community Score4.84.14.94.83.6
Dividend Score0.02.50.01.72.5
Ownership Score2.50.02.53.30.0
Earnings & Valuation Score1.91.31.31.31.9
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$688.85N/A$117.93$179.91$50.75
% Upside from Price Target-1.00% downsideN/A5.04% upside10.09% upside23.99% upside
Trade Information
Market Cap$55.07 billion$39.85 billion$69.79 billion$34.07 billion$17.99 billion
Beta1.690.281.091.340.71
Average Volume559,11387,3392,303,3741,076,906444,057
Sales & Book Value
Annual Revenue$2.47 billion$2.76 billion$4.39 billion$7.02 billion$4.56 billion
Price / Sales22.2814.4315.914.853.95
Cashflow$24.37 per share$0.35 per share$2.07 per share$13.85 per share$2.56 per share
Price / Cash28.5552.4754.3011.8015.99
Book Value$42.77 per share$0.48 per share$7.34 per share$58.85 per share$12.04 per share
Price / Book16.2738.4415.302.783.40
Profitability
Net Income$1.78 billion$585.21 million$823.40 million$-138,900,000.00$448 million
EPS$22.41$0.30$1.86$5.67$1.29
Trailing P/E Ratio79.2565.8948.1860.7531.73
Forward P/E Ratio63.5451.2544.5518.6819.68
P/E Growth3.35N/A3.222.421.60
Net Margins20.10%21.62%29.69%8.01%N/A
Return on Equity (ROE)21.42%69.30%30.81%9.85%N/A
Return on Assets (ROA)14.17%33.77%19.49%4.94%N/A
Dividend
Annual PayoutN/A$0.22N/A$0.96$0.90
Dividend YieldN/A1.19%N/A0.59%2.20%
Three-Year Dividend GrowthN/AN/AN/AN/A102.70%
Payout RatioN/A73.33%N/A16.93%69.77%
Years of Consecutive Dividend GrowthN/AN/AN/A1 Years1 Years
Debt
Debt-to-Equity RatioN/A0.02%0.13%0.61%0.64%
Current Ratio1.32%1.29%3.84%2.39%2.76%
Quick Ratio1.41%0.90%2.88%1.19%1.76%
Ownership Information
Institutional Ownership Percentage84.13%0.10%80.29%88.34%9.71%
Insider Ownership Percentage0.70%N/A1.35%0.56%1.00%
Miscellaneous
Employees18,07012,50014,90020,00018,000
Shares Outstanding79.14 million2.16 billion621.64 million208.48 million439.57 million
Next Earnings Date10/20/2021 (Estimated)N/A10/20/2021 (Estimated)8/3/2021 (Confirmed)N/A
OptionableOptionableNot OptionableOptionableOptionableOptionable
SourceHeadline
Smith & Nephew plc (NYSE:SNN) Up Almost 0.85% In One Month, Looking Good For The Long TermSmith & Nephew plc (NYSE:SNN) Up Almost 0.85% In One Month, Looking Good For The Long Term
marketingsentinel.com - July 29 at 6:07 PM
Smith & Nephew (NYSE:SNN) Shares Gap Down to $43.70Smith & Nephew (NYSE:SNN) Shares Gap Down to $43.70
americanbankingnews.com - July 29 at 11:28 AM
Smith+Nephew Q2 Revenue Up 48.2%; On-track To Meet FY GuidanceSmith+Nephew Q2 Revenue Up 48.2%; On-track To Meet FY Guidance
nasdaq.com - July 29 at 7:50 AM
Smith & Nephew (NYSE:SNN) Downgraded by Zacks Investment ResearchSmith & Nephew (NYSE:SNN) Downgraded by Zacks Investment Research
marketbeat.com - July 24 at 5:59 AM
Study shows Smith+Nephews REGENETEN™ Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tearsStudy shows Smith+Nephew's REGENETEN™ Bioinductive Implant sets new standard of recovery for partial-thickness rotator cuff tears
finance.yahoo.com - July 21 at 8:14 AM
Smith & Nephew plc (NYSE:SNN) Short Interest UpdateSmith & Nephew plc (NYSE:SNN) Short Interest Update
americanbankingnews.com - July 18 at 10:58 PM
Smith & Nephew (NYSE:SNN) Sees Strong Trading VolumeSmith & Nephew (NYSE:SNN) Sees Strong Trading Volume
americanbankingnews.com - July 16 at 12:58 PM
Scientists develop bendable iceScientists develop bendable ice
news.yahoo.com - July 15 at 6:43 PM
Smith+Nephew launches Real Intelligence and CORIâ„¢ Surgical System, next generation robotics platform, in IndiaSmith+Nephew launches Real Intelligence and CORIâ„¢ Surgical System, next generation robotics platform, in India
news.webindia123.com - July 12 at 11:53 PM
Smith+Nephew launches Real Intelligence and CORI™ Surgical System, next generation robotics platform, in IndiaSmith+Nephew launches Real Intelligence and CORI™ Surgical System, next generation robotics platform, in India
prnewswire.com - July 12 at 11:53 PM
Reviewing Eargo (NASDAQ:EAR) and Smith & Nephew (NYSE:SNN)Reviewing Eargo (NASDAQ:EAR) and Smith & Nephew (NYSE:SNN)
americanbankingnews.com - July 8 at 3:10 AM
Head-To-Head Survey: United Health Products (OTCMKTS:UEEC) versus Smith & Nephew (NYSE:SNN)Head-To-Head Survey: United Health Products (OTCMKTS:UEEC) versus Smith & Nephew (NYSE:SNN)
americanbankingnews.com - July 7 at 5:10 PM
Smith+Nephew launches Fast-Fix Flex meniscal repair systemSmith+Nephew launches Fast-Fix Flex meniscal repair system
massdevice.com - July 7 at 12:22 PM
Barclays Reiterates "Overweight" Rating for Smith & Nephew (NYSE:SNN)Barclays Reiterates "Overweight" Rating for Smith & Nephew (NYSE:SNN)
marketbeat.com - July 1 at 12:29 PM
Artificial joint maker Smith & Nephew given Covid bounceArtificial joint maker Smith & Nephew given Covid bounce
thetimes.co.uk - June 9 at 9:42 AM
Smith & Nephew Plc (SNN): Price Now Near $43.25; Daily Chart Shows An Uptrend on 50 Day BasisSmith & Nephew Plc (SNN): Price Now Near $43.25; Daily Chart Shows An Uptrend on 50 Day Basis
etfdailynews.com - June 2 at 2:17 PM
July 16th Options Now Available For Smith & Nephew (SNN)July 16th Options Now Available For Smith & Nephew (SNN)
nasdaq.com - May 20 at 1:34 PM
9 medical devices you should keep an eye out for in 20219 medical devices you should keep an eye out for in 2021
medicaldesignandoutsourcing.com - April 16 at 2:55 PM
Bullish Two Hundred Day Moving Average Cross - SNNBullish Two Hundred Day Moving Average Cross - SNN
nasdaq.com - April 16 at 2:55 PM
Smith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring SystemSmith+Nephew: Randomized Clinical Trial Shows Benefit Of LEAF Patient Monitoring System
nasdaq.com - April 13 at 10:56 AM
Smith & Nephew PLC Stock Shows Every Sign Of Being Fairly ValuedSmith & Nephew PLC Stock Shows Every Sign Of Being Fairly Valued
finance.yahoo.com - April 2 at 1:27 PM
How Does Smith & Nephews Debt Look?How Does Smith & Nephew's Debt Look?
finance.yahoo.com - March 15 at 12:42 PM
UPDATE 1-U.S. Supreme Court questions patent tribunals constitutionalityUPDATE 1-U.S. Supreme Court questions patent tribunal's constitutionality
finance.yahoo.com - March 1 at 3:32 PM
Berenberg lowers target price on Smith & NephewBerenberg lowers target price on Smith & Nephew
lse.co.uk - February 22 at 2:11 PM
MARKET REPORT: Cancelled surgeries bring pain to Smith & NephewMARKET REPORT: Cancelled surgeries bring pain to Smith & Nephew
msn.com - February 18 at 6:57 PM
Medical equipment firm Smith & Nephews profits hit as hospitals postpone surgeries to treat Covid patientsMedical equipment firm Smith & Nephew's profits hit as hospitals postpone surgeries to treat Covid patients
msn.com - February 18 at 8:56 AM
John Ma joins Smith+Nephews Board as NEDJohn Ma joins Smith+Nephew's Board as NED
sharecast.com - February 11 at 10:22 PM
DateCompanyBrokerageAction
7/30/2021Edwards LifesciencesCredit Suisse Group
Boost Price Target
7/30/2021Edwards LifesciencesMorgan Stanley
Boost Price Target
7/30/2021Edwards LifesciencesOppenheimer
Boost Price Target
7/30/2021Edwards LifesciencesStifel Nicolaus
Boost Price Target
7/30/2021Edwards LifesciencesUBS Group
Boost Price Target
7/30/2021Edwards LifesciencesSVB Leerink
Boost Price Target
7/30/2021Edwards LifesciencesCanaccord Genuity
Boost Price Target
7/30/2021Edwards LifesciencesJefferies Financial Group
Boost Price Target
7/30/2021Edwards LifesciencesWells Fargo & Company
Boost Price Target
7/30/2021Edwards LifesciencesDeutsche Bank Aktiengesellschaft
Boost Price Target
7/29/2021Align TechnologyWilliam Blair
Reiterated Rating
7/29/2021Align TechnologyCredit Suisse Group
Boost Price Target
7/29/2021Align TechnologyPiper Sandler
Boost Price Target
7/27/2021Edwards LifesciencesPiper Sandler
Boost Price Target
7/23/2021Edwards LifesciencesCowen
Boost Price Target
7/20/2021Edwards LifesciencesSVB Leerink
Boost Price Target
7/15/2021Coloplast A/SBarclays
Reiterated Rating
7/9/2021Align TechnologyStephens
Upgrade
7/8/2021Align TechnologyExane BNP Paribas
Initiated Coverage
7/8/2021Align TechnologyBNP Paribas
Initiated Coverage
7/1/2021Smith & NephewBarclays
Reiterated Rating
6/9/2021Smith & NephewCredit Suisse Group
Upgrade
5/28/2021Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
5/25/2021Zimmer BiometBarclays
Initiated Coverage
5/24/2021Edwards LifesciencesBarclays
Initiated Coverage
5/18/2021Coloplast A/SBerenberg Bank
Reiterated Rating
5/17/2021Zimmer BiometJMP Securities
Boost Price Target
5/11/2021Zimmer BiometJMP Securities
Boost Price Target
5/7/2021Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
5/5/2021Zimmer BiometTruist Securities
Boost Price Target
5/5/2021Zimmer BiometTruist
Boost Price Target
5/5/2021Zimmer BiometCanaccord Genuity
Boost Price Target
5/5/2021Zimmer BiometRaymond James
Boost Price Target
5/5/2021Zimmer BiometSVB Leerink
Boost Price Target
5/5/2021Zimmer BiometOppenheimer
Boost Price Target
5/4/2021Smith & NephewBerenberg Bank
Reiterated Rating
5/4/2021Smith & NephewCredit Suisse Group
Reiterated Rating
4/30/2021Smith & NephewBarclays
Reiterated Rating
4/30/2021Smith & NephewCanaccord Genuity
Boost Price Target
4/29/2021Align TechnologySVB Leerink
Boost Price Target
4/29/2021Align TechnologyCredit Suisse Group
Boost Price Target
4/29/2021Align TechnologyStifel Nicolaus
Boost Price Target
4/29/2021Align TechnologyRobert W. Baird
Boost Price Target
4/29/2021Align TechnologyPiper Sandler
Boost Price Target
4/22/2021Align TechnologyBerenberg Bank
Upgrade
4/21/2021Edwards LifesciencesMorgan Stanley
Boost Price Target
4/21/2021Edwards LifesciencesRaymond James
Boost Price Target
4/21/2021Edwards LifesciencesWells Fargo & Company
Boost Price Target
4/21/2021Edwards LifesciencesCanaccord Genuity
Boost Price Target
4/21/2021Edwards LifesciencesPiper Sandler
Boost Price Target
4/15/2021Align TechnologySVB Leerink
Boost Price Target
4/15/2021Edwards LifesciencesAtlantic Securities
Initiated Coverage
4/15/2021Zimmer BiometNorthland Securities
Upgrade
4/9/2021Zimmer BiometNorthland Securities
Upgrade
4/5/2021Edwards LifesciencesEvercore ISI
Upgrade
3/31/2021Smith & NephewBarclays
Reiterated Rating
3/9/2021Coloplast A/SCommerzbank
Upgrade
3/8/2021Coloplast A/SBarclays
Upgrade
3/8/2021Zimmer BiometOppenheimer
Boost Price Target
3/1/2021Zimmer BiometWells Fargo & Company
Boost Price Target
2/23/2021Smith & NephewBerenberg Bank
Reiterated Rating
2/22/2021Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
2/22/2021Smith & NephewCredit Suisse Group
Reiterated Rating
2/22/2021Smith & NephewCommerzbank
Downgrade
2/19/2021Smith & NephewCanaccord Genuity
Lower Price Target
2/9/2021Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
2/8/2021Zimmer BiometMorgan Stanley
Boost Price Target
2/8/2021Zimmer BiometRaymond James
Boost Price Target
2/8/2021Zimmer BiometWells Fargo & Company
Boost Price Target
2/8/2021Zimmer BiometSVB Leerink
Boost Price Target
2/8/2021Zimmer BiometDeutsche Bank Aktiengesellschaft
Boost Price Target
2/5/2021Zimmer BiometNeedham & Company LLC
Boost Price Target
2/5/2021Zimmer BiometOppenheimer
Initiated Coverage
2/5/2021Zimmer BiometPiper Sandler
Boost Price Target
2/4/2021Align TechnologyEvercore ISI
Boost Price Target
2/4/2021Align TechnologyCredit Suisse Group
Boost Price Target
2/4/2021Align TechnologySVB Leerink
Boost Price Target
2/4/2021Align TechnologyBarclays
Boost Price Target
2/3/2021Coloplast A/SMorgan Stanley
Reiterated Rating
2/2/2021Align TechnologyPiper Sandler
Boost Price Target
1/27/2021Zimmer BiometJMP Securities
Boost Price Target
1/25/2021Zimmer BiometBTIG Research
Boost Price Target
1/22/2021Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
1/21/2021Smith & NephewBarclays
Reiterated Rating
1/20/2021Coloplast A/SBerenberg Bank
Upgrade
1/20/2021Smith & NephewBerenberg Bank
Reiterated Rating
1/13/2021Coloplast A/SBarclays
Reiterated Rating
1/8/2021Zimmer BiometPiper Sandler
Boost Price Target
1/6/2021Zimmer BiometTruist Financial
Boost Price Target
1/4/2021Align TechnologyEvercore ISI
Upgrade
12/18/2020Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
12/18/2020Smith & NephewSanford C. Bernstein
Upgrade
12/16/2020Edwards LifesciencesSmith Barney Citigroup
Downgrade
12/14/2020Edwards LifesciencesMorgan Stanley
Boost Price Target
12/11/2020Edwards LifesciencesRaymond James
Boost Price Target
12/11/2020Edwards LifesciencesCanaccord Genuity
Boost Price Target
12/9/2020Coloplast A/SMorgan Stanley
Reiterated Rating
12/9/2020Smith & NephewMorgan Stanley
Reiterated Rating
12/1/2020Smith & NephewBarclays
Initiated Coverage
11/24/2020Align TechnologyCredit Suisse Group
Boost Price Target
11/24/2020Align TechnologySVB Leerink
Boost Price Target
11/24/2020Align TechnologyThe Goldman Sachs Group
Boost Price Target
11/24/2020Align TechnologyRobert W. Baird
Boost Price Target
11/23/2020Align TechnologyPiper Sandler
Boost Price Target
11/6/2020Coloplast A/SMorgan Stanley
Reiterated Rating
11/4/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
10/30/2020Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
10/30/2020Smith & NephewCanaccord Genuity
Lower Price Target
10/28/2020Align TechnologyStifel Nicolaus
Boost Price Target
10/16/2020Coloplast A/SBerenberg Bank
Reiterated Rating
9/23/2020Coloplast A/SBarclays
Downgrade
9/23/2020Coloplast A/SJefferies Financial Group
Upgrade
8/19/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
8/19/2020Coloplast A/SMorgan Stanley
Reiterated Rating
8/11/2020Coloplast A/SNordea Equity Research
Downgrade
7/31/2020Smith & NephewBerenberg Bank
Reiterated Rating
7/30/2020Smith & NephewJPMorgan Chase & Co.
Reiterated Rating
7/30/2020Smith & NephewMorgan Stanley
Reiterated Rating
4/27/2020Coloplast A/SBarclays
Reiterated Rating
4/20/2020Coloplast A/SJPMorgan Chase & Co.
Reiterated Rating
3/18/2020Coloplast A/SJPMorgan Chase & Co.
Upgrade
7/19/2019Coloplast A/SBarclays
Downgrade
(Data available from 7/31/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.